• Users Online: 66
  • Home
  • Print this page
  • Email this page
Home Current issue Ahead of print Search About us Editorial board Archives Submit article Instructions Subscribe Contacts Login 
ORIGINAL ARTICLE
Year : 2013  |  Volume : 106  |  Issue : 3  |  Page : 172-179

Triple intravitreal bevacizumab, sub-Tenon's triamcinolone, and panretinal photocoagulation in Eales' disease


Ophthalmology Department, Mansoura University, Mansoura, Egypt

Correspondence Address:
Abeer Khattab
Ophthalmology Department, Mansoura University, Mansoura
Egypt
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/2090-0686.127380

Rights and Permissions

Introduction Eales' disease (ED) is an idiopathic inflammatory vasoproliferative retinal disease primarily affecting the peripheral retina of young and apparently healthy adult men, mostly from the Indian subcontinent. It is characterized by peripheral retinal inflammation, retinal neovascularization, and recurrent vitreous hemorrhage, with or without retinal detachment. Objective This study was carried out to evaluate triple therapy, with intravitreal bevacizumab (IVB), posterior sub-Tenon's (SBT) triamcinolone, and panretinal photocoagulation (PRP), in ED patients with vitreous hemorrhage and its associated vasculitis, neovascularization, and macular edema. Design This was a prospective, interventional case series. Patients and methods This study included 20 eyes of 20 patients with vitreous hemorrhage because of ED. Preoperative evaluation included patient age, sex, race, medical history, medications, complete ophthalmological examination, and diagnostic laboratory evaluation. All eyes were treated with IVB, posterior SBT triamcinolone, and PRP. The follow-up period was up to 6 months. The main outcome measures were visual acuity, intraocular pressure changes, and recurrence of vitreous hemorrhage. Results A statistically significant improvement in visual acuity was observed at 1 week and 1, 3, and 6 months postoperatively. There was no statistically significant change in intraocular pressure at any of the postoperative follow-up intervals. There was no intraoperative or postoperative complication. None of the patients included had any recurrence during the follow-up. Conclusion The triple therapy with IVB, posterior SBT triamcinolone, and PRP seems to be effective in the treatment of ED patients with dense vitreous hemorrhage and its associated vasculitis, neovascularization, and macular edema.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed2529    
    Printed87    
    Emailed0    
    PDF Downloaded165    
    Comments [Add]    

Recommend this journal